Other headlines for [NUVA]

• NUVA 11/19/2008 11:44am
  NuVasive Inc Hearing defended at Piper Jaffray (timing uncertain)
  
• NUVA 10/22/2008 04:39pm
  NuVasive Inc Reports Q3 $0.21 v $0.01e, R $66.9M v $60.9Me- Guides FY08 EPS $0.05-$0.07 v $0.05e, R $245M-$247M v $240.3Me. - Cash, cash equivalents and short and long-term investments were $221.7M at September more...
  
• NUVA 10/21/2008 08:53am
  NuVasive Inc Stanford Group Analyst Raised NUVA to Buy from Hold, price target: $53
  
• NUVA 10/16/2008 08:26am
  NuVasive Inc Brean Murray Initiates NUVA with Buy, price target: $55
  
• NUVA 10/13/2008 06:34am
  NuVasive Inc Wachovia Raised NUVA to Outperform from Market Perform
  

Healthcare sector headlines

• NPSP Today 08:50am
  NPS Pharmaceuticals Inc. Update: Initiates Phase 3 'STEPS' Study to Confirm GATTEX Reduces Parenteral Nutrition Dependence in Short Bowel Syndrome- Patient enrollment has begun in a Phase 3 registrational study to confirm more...
  
• OCLS Today 08:48am
  Oculus Innovative Sciences Update: Signs development agreement with Bayer Taiwan for Microcyn tech in Taiwanese animal market- As part of the agreement, Bayer Taiwan Co. Ltd. will be responsible for securing Taiwanese more...
  
• TPTX Today 08:47am
  TorreyPines Therapeutics Update: Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia- Announced positive results from a 26 patient Phase II trial evaluating three doses of NGX267 as more...
  
• CUR Today 08:02am
  Neuralstem Inc Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials- The collaboration will focus on Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with Dr. more...
  
• SVA Today 08:01am
  Sinovac Biotech Announces share buyback of up to $2M (5.5% of market cap)